Business Wire

Afiniti Appoints Hassan Afzal as Its Chief Executive Officer

Share

Afiniti, the leading provider of AI-enabled enterprise behavioral pairing solutions for customer interactions, has announced the appointment of Hassan Afzal as Afiniti’s Chief Executive Officer and Board Director.

Mr. Afzal, an experienced business leader, will succeed Larry Babbio, who assumed the position of Chief Executive Officer of Afiniti in 2021. His appointment is the culmination of a CEO succession plan and subsequent search process undertaken by the Board. The Board of Directors is grateful to Mr. Babbio for his unwavering commitment to Afiniti and is pleased that the company will continue to benefit from his experience as he will remain with Afiniti as a Board Director.

Mr. Afzal joined Afiniti in 2007 as one of its first employees and has served as its Chief Technology Officer, making him a key architect of Afiniti’s unique and patented technology. He has been a core enabler of Afiniti’s growth to its current scale of about 1,500 employees across 20 countries. Mr. Afzal holds a MSc in Computer and Information Systems from the University of Pennsylvania and a BSE in Electrical Engineering from the University of Virginia.

“I am looking forward to leading this great company and leveraging the strength of our people, culture and our customer-centric focus,” said Mr. Afzal. “As a pioneer in using artificial intelligence technology to measurably optimize customer interactions, Afiniti has an exciting opportunity to deploy more intelligence and automation within the customer experience. I will work with Larry and the Board on a seamless transition and thank Larry for his guidance over the last two years.”

“Hassan has brought a wealth of experience with excellent strategic and leadership skills to Afiniti, and we are delighted that he will be our Chief Executive Officer,” said Mr. Babbio. “He has impressed the Board with the impact he has made at Afiniti, where he has brought a strong client-centric mindset and creative technology leadership. The Board believes his leadership skills and experience will lead Afiniti through its next strategic phase.”

About Afiniti

Afiniti uses patented artificial intelligence technology to pair participants in customer interactions based on how well they are likely to interact. Its technology is used globally in the healthcare, telecommunications, travel, hospitality, insurance, and banking industries, and across multiple customer experience channels. To learn more, visit www.afiniti.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

media@afiniti.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Cirium Ascend Consultancy Lands ‘Appraiser of the Year’ Title for the 10th Time14.1.2025 10:00:00 EET | Press release

Cirium Ascend Consultancy, part of the world’s most trusted source of aviation analytics, Cirium, has once again landed Airline Economics’ prestigious title of ‘Appraiser of the Year’ at an award ceremony last night. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113971776/en/ Cirium awarded 'Appraiser of the Year' (Photo: Business Wire) This marks the tenth win for Cirium Ascend Consultancy, demonstrating its unparalleled expertise within aviation consultancy and underlining its unwavering commitment to excellence, transparency and accuracy. The annual award was presented to Rob Morris, Global Head of Cirium Ascend Consultancy, at the Airline Economics Aviation 100 Global Leaders Awards 2025 in Dublin, Ireland, which celebrates the best companies, individuals and transactions in the aviation finance and leasing sector. 2025’s landmark win makes it the first time a single firm has won the title 10 times, recognising Ciriu

Lincotek Appoints New Group Chief Financial Officer14.1.2025 08:00:00 EET | Press release

Lincotek Group – the global solution provider for the Energy, Aerospace and Medical Device sectors – this week announced the appointment of Vittorio Tavanti as its new Group Chief Financial Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113830801/en/ Vittorio Tavanti - Lincotek new Group Chief Financial Officer (Photo: Business Wire) In addition to his appointment as CFO, Tavanti will also take on an acting role as Chief Information Officer – a new position reflecting the critical part played by technology in Lincotek’s success. Tavanti brings a wealth of experience and a proven track record in driving strategic growth and operational excellence across a variety of businesses over a 20-year career, including Siemens, General Electric Oil & Gas and Baker Huges, as well as Schneider Electric. Most recently, Vittorio held the role of Group Chief Financial Officer – Investor Relator and IT of the Italian stock-exchan

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss14.1.2025 08:00:00 EET | Press release

Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weight loss with associated facial volume loss.1 Initial three-month interim data from this first-of-its-kind trial suggest that this treatment combination effectively improved facial aesthetic appearance with high patient satisfaction.1 The results will be presented later today at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Rates of medication-driven weight loss have increased rapidly in recent years and can be associated with facial alterations of variable magnitude.2-4 Patients can find that their skin is less radiant, drier or saggy, and can also observe changes in their facial structure and balance.3,4 Some even find that they appear older than their age.3,4 There are several reasons for these facial alterations including loss of fat, collagen, elastin

Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth14.1.2025 08:00:00 EET | Press release

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook. The company’s CEO and president Carlos Gallardo will highlight a new era for its business starting in 2025 – forecasting sustained double-digit growth of net sales (CAGR 2023-2030) and a substantial margin expansion, driven by Almirall’s focus on medical dermatology, commercial excellence, and its continued investment in R&D to innovate and advance science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113044812/en/ Almirall HQ in Barcelona (Photo: Business Wire) Almirall combines the strengthening of its growth drivers, particularly the biologics products, with the continued growth of its broad portfolio of medical dermatology solutions, including Klisyri®, Wynzora®, and Seysara®. Almirall’s commercial excellence has been demons

Mesmerise to collaborate with Mayo Clinic to Transform Medical Education and Healthcare Workforce Training14.1.2025 00:10:00 EET | Press release

Mesmerise is proud to announce the creation of NeuRealities, Inc., a transformative company designed to revolutionize medical education and healthcare training. As part of a know-how agreement with Mayo Clinic, the new company seeks to leverage Mayo Clinic’s unparalleled clinical expertise and trusted knowledge with Mesmerise’s pioneering advancements in AI-powered spatial computing to set a new standard for excellence in immersive learning experiences. NeuRealities aims to introduce an open-standards digital platform that redefines how healthcare professionals learn and train. By integrating hyper-realistic AI-enabled digital humans, adaptive immersive experiences, and dynamic content tailored to individual learners, the platform can address critical gaps in medical education. Its first initiative—CT training for radiologic technicians—delivers interactive, hands-on scenarios that simplify complex medical concepts, allowing the potential for training to be more efficient, accessible,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye